Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Cyclophosphamide Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Cyclophosphamide Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Cyclophosphamide Powder
      • 1.3.3 Cyclophosphamide Injection
    • 1.4 Market Segment by Application
      • 1.4.1 Global Cyclophosphamide Market Share by Application (2019-2025)
      • 1.4.2 Cancer
      • 1.4.3 Autoimmune Diseases
      • 1.4.4 AL Amyloidosis
      • 1.4.5 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Cyclophosphamide Production Value 2014-2025
      • 2.1.2 Global Cyclophosphamide Production 2014-2025
      • 2.1.3 Global Cyclophosphamide Capacity 2014-2025
      • 2.1.4 Global Cyclophosphamide Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Cyclophosphamide Market Size CAGR of Key Regions
      • 2.2.2 Global Cyclophosphamide Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Cyclophosphamide Capacity by Manufacturers
      • 3.1.2 Global Cyclophosphamide Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Cyclophosphamide Revenue by Manufacturers (2014-2019)
      • 3.2.2 Cyclophosphamide Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Cyclophosphamide Market Concentration Ratio (CR5 and HHI)
    • 3.3 Cyclophosphamide Price by Manufacturers
    • 3.4 Key Manufacturers Cyclophosphamide Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Cyclophosphamide Market
    • 3.6 Key Manufacturers Cyclophosphamide Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Cyclophosphamide Powder Production and Production Value (2014-2019)
      • 4.1.2 Cyclophosphamide Injection Production and Production Value (2014-2019)
    • 4.2 Global Cyclophosphamide Production Market Share by Type
    • 4.3 Global Cyclophosphamide Production Value Market Share by Type
    • 4.4 Cyclophosphamide Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Cyclophosphamide Consumption by Application

    6 Production by Regions

    • 6.1 Global Cyclophosphamide Production (History Data) by Regions 2014-2019
    • 6.2 Global Cyclophosphamide Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Cyclophosphamide Production Growth Rate 2014-2019
      • 6.3.2 United States Cyclophosphamide Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Cyclophosphamide Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Cyclophosphamide Production Growth Rate 2014-2019
      • 6.4.2 European Union Cyclophosphamide Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Cyclophosphamide Import & Export
    • 6.5 China
      • 6.5.1 China Cyclophosphamide Production Growth Rate 2014-2019
      • 6.5.2 China Cyclophosphamide Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Cyclophosphamide Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Cyclophosphamide Consumption by Regions

    • 7.1 Global Cyclophosphamide Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Cyclophosphamide Consumption by Type
      • 7.2.2 United States Cyclophosphamide Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Cyclophosphamide Consumption by Type
      • 7.3.2 European Union Cyclophosphamide Consumption by Application
    • 7.4 China
      • 7.4.1 China Cyclophosphamide Consumption by Type
      • 7.4.2 China Cyclophosphamide Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Cyclophosphamide Consumption by Type
      • 7.5.2 Rest of World Cyclophosphamide Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Baxter
      • 8.1.1 Baxter Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Cyclophosphamide
      • 8.1.4 Cyclophosphamide Product Introduction
      • 8.1.5 Baxter Recent Development
    • 8.2 Roxane
      • 8.2.1 Roxane Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Cyclophosphamide
      • 8.2.4 Cyclophosphamide Product Introduction
      • 8.2.5 Roxane Recent Development
    • 8.3 GLS Pharma Ltd
      • 8.3.1 GLS Pharma Ltd Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Cyclophosphamide
      • 8.3.4 Cyclophosphamide Product Introduction
      • 8.3.5 GLS Pharma Ltd Recent Development
    • 8.4 Sanofi
      • 8.4.1 Sanofi Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Cyclophosphamide
      • 8.4.4 Cyclophosphamide Product Introduction
      • 8.4.5 Sanofi Recent Development
    • 8.5 CSC PHARMACEUTICALS INTERNATIONAL
      • 8.5.1 CSC PHARMACEUTICALS INTERNATIONAL Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Cyclophosphamide
      • 8.5.4 Cyclophosphamide Product Introduction
      • 8.5.5 CSC PHARMACEUTICALS INTERNATIONAL Recent Development
    • 8.6 LGM Pharma
      • 8.6.1 LGM Pharma Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Cyclophosphamide
      • 8.6.4 Cyclophosphamide Product Introduction
      • 8.6.5 LGM Pharma Recent Development
    • 8.7 Pfizer
      • 8.7.1 Pfizer Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Cyclophosphamide
      • 8.7.4 Cyclophosphamide Product Introduction
      • 8.7.5 Pfizer Recent Development
    • 8.8 Merck
      • 8.8.1 Merck Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Cyclophosphamide
      • 8.8.4 Cyclophosphamide Product Introduction
      • 8.8.5 Merck Recent Development
    • 8.9 Allergan
      • 8.9.1 Allergan Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Cyclophosphamide
      • 8.9.4 Cyclophosphamide Product Introduction
      • 8.9.5 Allergan Recent Development
    • 8.10 The Medicines Company
      • 8.10.1 The Medicines Company Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Cyclophosphamide
      • 8.10.4 Cyclophosphamide Product Introduction
      • 8.10.5 The Medicines Company Recent Development
    • 8.11 Theravance Biopharma
    • 8.12 Basilea Pharmaceutica

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Cyclophosphamide Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Cyclophosphamide Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Cyclophosphamide Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Cyclophosphamide Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Cyclophosphamide Production Forecast by Type
      • 9.7.2 Global Cyclophosphamide Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Cyclophosphamide Sales Channels
      • 10.2.2 Cyclophosphamide Distributors
    • 10.3 Cyclophosphamide Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      In 2019, the market size of Cyclophosphamide is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cyclophosphamide.

      This report studies the global market size of Cyclophosphamide, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Cyclophosphamide production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Baxter
      Roxane
      GLS Pharma Ltd
      Sanofi
      CSC PHARMACEUTICALS INTERNATIONAL
      LGM Pharma
      Pfizer
      Merck
      Allergan
      The Medicines Company
      Theravance Biopharma
      Basilea Pharmaceutica

      Market Segment by Product Type
      Cyclophosphamide Powder
      Cyclophosphamide Injection

      Market Segment by Application
      Cancer
      Autoimmune Diseases
      AL Amyloidosis
      Other

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Cyclophosphamide status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Cyclophosphamide manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Cyclophosphamide are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now